Search

everythinglearnresearchcommunity

for

Search:↓

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

A genetic change in the EDAR gene causes the unique hair traits found in East Asians.

TNF family proteins are crucial for the development of skin features like hair, teeth, and mammary glands.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Noggin overexpression delays eyelid opening by affecting cell death and skin cell development.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

In Brazil in 2018, the most common skin issues were acne, photoaging, and nonmelanoma skin cancer, with treatments often including topical medications and sunscreen.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.